HIGHLIGHTS
- who: Background et al. from the University of Edinburgh, United United Kingdom have published the article: International Journal of Population Data Science, in the Journal: (JOURNAL)
- what: As costs at the end of life are frequently included in health economic models of new cancer drugs for reimbursement submissions, this study provides data that will be of direct use for this purpose.
- future: Future studies should arguably incorporate a mixed methods approach whereby routine data provides objective data relating to clinical pathways and costs and qualitative research alongside illuminates the subjective lived experience. Research . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.